ARTL סך נכסי הפעילות העסקית Artelo
Artelo Biosciences (ARTL) focuses on studying cannabinoid therapies, optimizing supply chains and its contract base to mitigate risks. The company maintains its intellectual capital by recruiting top biochemists and compliance experts. This chart of total asset quotes shows a value of 5.41. The business model relies on outsourcing formula synthesis and clinical trials to external partners, allowing Artelo Biosciences (ARTL) to operate as a pure scientific hub.
פילוחים אנליטיים ודוחות נתונים של חברת artelobio.com (ARTL)
Developing innovative drugs for cancer therapy and chronic pain requires significant resources; therefore, total assets, representing the sum of capital and liabilities, determine the financial scale of Artelo Biosciences (ARTL). A reverse calculation via ROA allows investors to perform a real-time assessment of asset utilization efficiency, where monitoring the company's total assets reveals the balance between R&D investments and the risk of freezing illiquid capital.